• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PYC

PYC THERAPEUTICS LIMITED - Charts / Financials

0.41% ! $1.21
Market Cap $708.6M  !
Healthcare Biotechnology
Add to My Watchlist

PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company... PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company creating a new generation of ribonucleic acid (RNA) therapies to change the lives of patients with genetic diseases. The Company utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The Company's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.More

refresh Created with Sketch. REFRESH
Last update - 10.19am 11/09/2025 (20 minute delay) ?
Day
Open $1.21   Day High $1.21   Day Low $1.21
Daily Volume 8738
Bids   Sellers
Number Price Volume   Number Price Volume
3 $1.20 7083   2 $1.22 6434

Directors & Senior Management

Dr. Rohan Hockings Chief Executive Officer, Executive Director
Mr. Andrew Taylor Chief Financial Officer, Joint Company Secretary
Dr. Glenn Noronha Chief Development Officer
Mr. Kevin R. Hart Joint Company Secretary
Mr. Alan Tribe Non-Executive Chairman of the Board
Mr. Jason Haddock Non-Executive Independent Director
Dr. Michael Rosenblatt Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$1.21 		Change
-0.005(0.41%) 		Mkt cap ! $708.6M
Open High Low Value Volume
$1.21 $1.21 $1.21 $10.57K 8.738K

Buyers (Bids)

No. Vol. Price($)
3 7083 $1.20
 

Sellers (Offers)

Price($) Vol. No.
$1.22 6434 2
View Market Depth
Last trade - 09.59am 11/09/2025 (20 minute delay) ?
Last
$1.19 		  Change
-0.005 ( 1.45 %)
Open High Low Volume
$1.19 $1.19 $1.19 7880
Last updated 10.19am 11/09/2025 ?

Top Stories

EV Resources snaps up Nevada antimony project; will raise $5.5M for it, Los Lirios

EV Resources has come out of its halt with a bang, unveiling the acquisition of the Dollar Antimony Project in Nye County alongside a raise.
ASX Market Open: Sour September winning out over blockbuster US AI rally | Sep 11 ASX traders waking up will be seeing the Oracle surge on Wall Street and more S&P and Nasdaq records, but don't expect that to trickle down.
Perenti's Barminco to keep working with Ramelius after winning $300M Dalgaranga contract Mine services group Perenti has landed a $300M contract through its underground subsidiary, Barminco, to work on the Dalgaranga Gold Project.
EVR opens strong with funding, acquisition, and sales agreement announcements EVR has caught attention on the HotCopper forums and across the wider Australian markets today with a flurry of announcements.
Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner In this HotCopper Wire Week 37 episode, we take a look at the Coles and Woolies legal fight and compare 4DMedical and 4DS Memory.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.